- Home
- Companies
- australasia
- clinical study
Show results for
Refine by
Industries served
- Medical / Health Care
- Monitoring and Testing
- Food and Beverage
- Environmental
- Chemical & Pharmaceuticals
- Agriculture
- Health and Safety
- Air and Climate
- Government
- Energy
- Defense
- Waste and Recycling
- Oil, Gas & Refineries
- Water and Wastewater
- University / Academia / Research
- Manufacturing, Other
- Construction & Construction Materials
Clinical Study Suppliers In Australasia
28 companies found
based inCottesloe, AUSTRALIA
Neuroscientific Biopharmaceuticals is an Australian public company (ASX:NSB) developing novel peptide-based pharmaceutical products that target a number of neurological disorders and diseases of the eye that have high unmet medical need. Our vision ...
EmtinB is the lead candidate that has shown to closely mimic the neuroprotective and neuroregenerative ability of MT-II. ...
based inNorth Ryde, AUSTRALIA
Biotron Limited (Biotron) is a clinical stage publicly listed Australian Biotechnology Company based in Sydney, Australia. The company is developing and commercialising a novel small molecule approach that has the potential to treat a number of ...
Biotron is developing novel small molecule antiviral therapeutics targeting a range of viruses including Hepatitis C virus (HCV) and ...
based inMontreal, QUEBEC (CANADA)
Novatek International provides a new breed of all-encompassing, process-driven laboratory information management system (LIMS) and other software solutions that target the pharmaceutical, biotech and other healthcare industries. Our unique portfolio ...
In clinical studies, assessing and managing risks, as well as establishing areas of uncertainty that contribute to risk, are critical to a company’s decision making processes. Many business units within ...
based inChristchurch, NEW ZEALAND
ARANZ Medical Ltd. is a healthcare informatics company focused on innovative medical imaging and data-capture devices, and analysis software. Wound Care Charting Silhouette is the complete charting solution for your wound ...
Silhouette delivers the data accuracy you need to prove your endpoints. 3D depth measurements. Consistent, clear images. Accurate, reliable data across users. Infection ...
based inParkville, AUSTRALIA
PolyActiva is an innovative clinical-stage ophthalmology company with a unique proprietary polymeric prodrug technology that enables site-specific, precise and controlled drug delivery to the eye. Our mission is to become a leader in ophthalmic ...
Being developed to reduce the risk of Endophthalmitis following ocular (cataract) surgery. Clinical Investigation Stage: Phase ...
based inCarlsbad, CALIFORNIA (USA)
Founded and headquartered in Brisbane, Australia, ImpediMed is a global company with operations in the United States and Europe. We are the world leader in the design and manufacture of medical devices employing bioimpedance spectroscopy (BIS) ...
ImpediVET is a single-channel, tetrapolar bioimpedance spectroscopy (BIS) device that measures fluid status and tissue composition for veterinary applications—from laboratory research to clinic. The device has been used on species as varied as ...
based inSalt Lake City, UTAH (USA)
Everything we do is designed to help you develop, manufacture and commercialize products that help people live longer, healthier and more enjoyable lives. Being a global leader starts with a commitment to being local. MasterControl has deep ...
based inMelbourne, AUSTRALIA
Starpharma Holdings Limited is a global biopharmaceutical company and a world leader in the development of new pharmaceutical and medical products based on proprietary polymers called dendrimers, with programs for COVID-19, DEP drug delivery and ...
DEP® docetaxel is an enhanced version of docetaxel (Taxotere®) – widely used for breast, lung & prostate cancer. Docetaxel (Taxotere®) is a commonly used chemotherapy agent despite having multiple US FDA “Black Box” ...
based inBundoora, AUSTRALIA
AdAlta is an innovative, clinical stage biotech company developing a unique range of new drug treatments. AdAlta has pioneered a technology that mimics the shape and stability of a crucial antigen-binding domain, discovered initially in sharks and ...
AdAlta is utilising the power of the i-body technology platform to develop a growing pipeline of i-bodies to treat a range of conditions, with an initial focus on treating fibrotic diseases. AdAlta identified an i-body that binds to the drug target, ...
based inBillerica, MASSACHUSETTS (USA)
Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists ...
based inBrunswick, AUSTRALIA
Avania is an integrated global, full-service CRO with specialized expertise in medical device, novel technology, and combination products. They advance products from feasibility all the way through post-approval trials in analytics, clinical trials, ...
Biotechnology research is an ever-evolving area of science that requires nimble teams and customized solutions. We have a track record of developing advanced therapeutics with limited resources and tight timelines. Our team has extensive biotech and ...
based inLund, SWEDEN
Camurus is committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New drug products are based on our ...
based inCambridge, MASSACHUSETTS (USA)
TriNetX is the global health research network that connects the world of drug discovery and development from pharmaceutical company to study site, and investigator to patient by sharing real-world data to make clinical and observational research ...
Ask the healthcare organizations who share their de-identified patient data to participate in your clinical study, right on our platform. Our live regional networks attribute each de-identified patient in your ...
based inMascot, AUSTRALIA
Since 2006, AusDiagnostics has been committed to bringing the benefits of molecular science to the world, to help enable better diagnostic decisions in human diagnostics, animal diagnostics and applied testing. The first MT-PCR panel was introduced ...
based inEast Brisbane, AUSTRALIA
Ellume is a digital diagnostics company that develops, manufactures, and commercializes high-performance, connected products for healthcare professionals and consumers. It is at the forefront of accurate, rapid and accessible testing that is ...
ellume·lab is a versatile, handheld digital device designed for healthcare professionals at the point of care. ellume·lab offers a growing range of highly accurate, rapid diagnostic tests for the detection of common infectious ...
based inMangere, NEW ZEALAND
Aroa Biosurgery is a soft-tissue regeneration company that develops, manufactures and distributes medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. Our first commercial surgical product, a Reinforced ...
based inBridgend, UNITED KINGDOM
Markes International is a specialist manufacturer of instrumentation for detection of trace-level volatile and semi-volatile organic compounds (VOCs and SVOCs). Markes has a well-deserved reputation for its application expertise in the field of ...
Markes’ BioVOC-2™ breath sampler is a lightweight and simple-to-use device designed for non-invasive biological exposure monitoring of VOCs. Using a design pioneered by the UK Health & Safety Executive, BioVOC-2 collects the last 129 ...
based inSouth Melbourne, AUSTRALIA
BioDiem is an Australian biopharmaceutical company that is focused on developing and commercialising vaccines and infectious disease therapies. Our business model is to generate income from partnerships including with other vaccine and infectious ...
A core technology advantage: Live Attenuated Influenza Virus (LAIV) vaccine. BioDiem’s lead asset is the Live Attenuated Influenza Virus (LAIV) vaccine technology. Our LAIV vaccine licensing business involves out-licensing of the ...
based inMelbourne, AUSTRALIA
Mesoblast is using its proprietary mesenchymal lineage cell technology platform to develop and commercialize innovative allogeneic cellular medicines to treat complex inflammatory diseases resistant to conventional standard of care. ...
MPC-25-IC is Mesoblast’s Phase 2 product candidate for the treatment of acute myocardial infarction. This is the first clinical study to evaluate an allogeneic cellular therapy delivered by intracoronary ...
based inTorrance, CALIFORNIA (USA)
Phenomenex isn’t your typical scientific company. Founded nearly 40 years ago, Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers ...